Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
32.37
+0.11 (0.34%)
Oct 20, 2025, 12:17 PM EDT - Market open
HRTS Holdings Information
HRTS is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 8.83%, UnitedHealth Group at 4.97%, AstraZeneca at 4.37%, Roche Holding AG at 4.31%, and Abbott Laboratories at 4.17%.
Total Holdings
46
Top 10 Percentage
44.09%
Asset Class
Equity
ETF Category
Health
Assets
50.65M
PE Ratio
21.19
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | LLY | Eli Lilly and Company | 8.83% |
2 | UNH | UnitedHealth Group Incorporated | 4.97% |
3 | LON: AZN | AstraZeneca PLC | 4.37% |
4 | RHHBY | Roche Holding AG | 4.31% |
5 | ABT | Abbott Laboratories | 4.17% |
6 | GILD | Gilead Sciences, Inc. | 3.86% |
7 | TMO | Thermo Fisher Scientific Inc. | 3.62% |
8 | BSX | Boston Scientific Corporation | 3.54% |
9 | ABBV | AbbVie Inc. | 3.26% |
10 | SWX: NOVN | Novartis AG | 3.16% |
11 | MDT | Medtronic plc | 3.11% |
12 | JNJ | Johnson & Johnson | 2.91% |
13 | CPH: NOVO.B | Novo Nordisk A/S | 2.77% |
14 | CYTK | Cytokinetics, Incorporated | 2.48% |
15 | VRTX | Vertex Pharmaceuticals Incorporated | 2.47% |
16 | DHR | Danaher Corporation | 2.44% |
17 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.42% |
18 | MRK | Merck & Co., Inc. | 2.31% |
19 | BBIO | BridgeBio Pharma, Inc. | 2.08% |
20 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.05% |
21 | AMGN | Amgen Inc. | 2.03% |
22 | REGN | Regeneron Pharmaceuticals, Inc. | 1.95% |
23 | MCK | McKesson Corporation | 1.91% |
24 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.84% |
25 | EW | Edwards Lifesciences Corporation | 1.79% |
As of Oct 16, 2025